Single User License
INR 170075
Site License
INR 340150
Corporate User License
INR 510225

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Retinal Vein Occlusion Global Clinical Trials Review, H1

Retinal Vein Occlusion Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Retinal Vein Occlusion Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Retinal Vein Occlusion Global Clinical Trials Review, H1, 2015" provides an overview of Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Retinal Vein Occlusion 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Retinal Vein Occlusion 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Retinal Vein Occlusion 33

Apr 23, 2015: ThromboGenics Starts Evaluating JETREA for the Treatment of Retinal Vein Occlusion 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Novartis AG 34

Clinical Trial Overview of Novartis AG 34

Actavis plc 36

Clinical Trial Overview of Actavis plc 36

F. Hoffmann-La Roche Ltd. 38

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 38

Regeneron Pharmaceuticals, Inc. 40

Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 40

Bayer AG 41

Clinical Trial Overview of Bayer AG 41

Valeant Pharmaceuticals International, Inc. 42

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 42

S:t Eriks Ogonsjukhus AB 43

Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 43

Pfizer Inc. 44

Clinical Trial Overview of Pfizer Inc. 44

California Retina Consultants 45

Clinical Trial Overview of California Retina Consultants 45

Asociacion para Evitar la Ceguera en Mexico I.A.P. 46

Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 46

Clinical Trial Overview of Top Institutes / Government 47

Shahid Beheshti University of Medical Sciences 47

Clinical Trial Overview of Shahid Beheshti University of Medical Sciences 47

National Eye Institute 48

Clinical Trial Overview of National Eye Institute 48

Shiga University of Medical Science 49

Clinical Trial Overview of Shiga University of Medical Science 49

Barnes Retina Institute 50

Clinical Trial Overview of Barnes Retina Institute 50

Duke University 51

Clinical Trial Overview of Duke University 51

Hallym University Medical Center 52

Clinical Trial Overview of Hallym University Medical Center 52

Manhattan Eye Ear & Throat Hospital 53

Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 53

Medical University of Vienna 54

Clinical Trial Overview of Medical University of Vienna 54

Mie University 55

Clinical Trial Overview of Mie University 55

Palo Alto Medical Foundation 56

Clinical Trial Overview of Palo Alto Medical Foundation 56

Five Key Clinical Profiles 57

Appendix 125

Abbreviations 125

Definitions 125

Research Methodology 126

Secondary Research 126

About GlobalData 127

Contact Us 127

Disclaimer 127

Source 127

List of Figures

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 126

List of Tables

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2015* 7

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15

Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18

Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Retinal Vein Occlusion Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Retinal Vein Occlusion Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Retinal Vein Occlusion Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 36

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 38

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015* 40

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 41

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 42

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2015* 43

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 44

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Retina Consultants, 2015* 45

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015* 46

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015* 47

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 48

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2015* 49

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2015* 50

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 51

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Hallym University Medical Center, 2015* 52

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2015* 53

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 54

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mie University, 2015* 55

Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Palo Alto Medical Foundation, 2015* 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novartis AG

Actavis plc

F. Hoffmann-La Roche Ltd.

Regeneron Pharmaceuticals, Inc.

Bayer AG

Valeant Pharmaceuticals International, Inc.

S:t Eriks Ogonsjukhus AB

Pfizer Inc.

California Retina Consultants

Asociacion para Evitar la Ceguera en Mexico I.A.P.

Retinal Vein Occlusion Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Retinal Vein Occlusion, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com